Quantcast

Latest Bacillus Calmette-Guérin Stories

2014-08-08 10:43:20

BMJ-British Medical Journal Although only effective in countries more than 40° latitude away from the equator The vaccine used to protect against tuberculosis disease (bacillus calmette-guerin or BCG) also protects against tuberculosis infection (mycobacterium) as well as protecting against progression from infection to disease, finds a paper published on thebmj.com today. The BCG vaccine has been subject to numerous trials and studies over several decades, which have shown that it...

2014-07-18 08:24:51

BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer. MCNA U.S. Regulatory Update Following several months of active dialogue with the U.S. Food and Drug Administration (FDA),...

2014-06-09 10:25:14

Queen's University TB blood test could eliminate unnecessary treatment A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives. According to research by Wendy Wobeser and medical resident Ilan Schwartz, a test for TB using interferon-gamma release assays (IGRA) will detect a pre-existing TB infection, or latent TB, that might not present itself for...

2014-03-24 12:29:41

Aeras releases TB Crisis Tracker on World TB Day ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues to impact pockets of the U.S. population, according to a data visualization tool developed by the nonprofit biotech, Aeras. Launched on World TB Day, Aeras's TB Crisis Tracker illustrates how the TB epidemic continues to impact the U.S. "TB's impact in the U.S. is but a fraction of what it once was, but the Aeras TB Crisis Tracker starkly...

2014-03-20 04:21:53

BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent tuberculosis infections, continues to grow rapidly around the world - Commercial launch of QuantiFERON-TB in China, where latent TB affects an estimated 41% of population, will support nationwide efforts to control TB - QIAGEN marks World TB Day 2014 on March 24 with QuantiFERON-TB...

Tuberculosis Vaccine Cure For MS
2013-12-05 11:34:05

Brett Smith for redOrbit.com - Your Universe Online A new preliminary study from a team of Italian researchers has found that a vaccine used to thwart tuberculosis outside the US could be used to treat multiple sclerosis (MS). In the study, which was published in the journal Neurology, scientists found people who had early symptoms of MS and MRI scans pointing to the development of the neurological condition benefited from receiving an injection of Bacille Calmette-Guérin, which is...

Tuberculosis Vaccine Shows Promising Results
2013-10-03 04:39:56

redOrbit Staff & Wire Reports - Your Universe Online Canadian researchers have developed a new tuberculosis vaccine that could boost or perhaps replace the only existing way to immunize against the infection. The researchers say the new vaccine is an important breakthrough because the current tuberculosis vaccine is not effective enough to curb the TB epidemic in some parts of the world. "We are the first to have developed such a vaccine for tuberculosis," said Dr. Fiona Smaill,...

2013-08-16 10:38:06

A new study has calculated the average cost per case of TB in the EU. The findings suggest the economic burden of TB far outweighs the costs of investing in more effective vaccines. The research, published online today (16 August 2013), in the European Respiratory Journal, is the first study to estimate the costs of the disease in recent years. Researchers used a systematic review of literature and institutional websites for the 27 EU member states to summarise economic data on the...

Tuberculosis Vaccine Fails Infant Trial
2013-02-04 14:42:30

[ Watch the Video: Discussing New Tuberculosis Vaccine Trials ] Lee Rannals for redOrbit.com - Your Universe Online A new vaccine considered to be the most advanced for tuberculosis (TB) among more than a dozen now in trials has failed its study. Researchers said they were disappointed by the results of the study, which showed that the vaccine offered little to no protection at all from TB. Nearly 3,000 babies in South Africa took part in the study, all of whom had already been...


Latest Bacillus Calmette-Guérin Reference Libraries

45_255d6ba67dfe6f32b9c7c31f338bf912
2011-04-18 22:11:24

Mycobacterium bovis is a slow-growing, aerobic bacterium and the causative agent of tuberculosis in cattle. Similar to M. tuberculosis, M. bovis can jump the species barrier and cause tuberculosis in humans. It is estimated that M. bovis was responsible for more losses among farm animals than all other diseases combined in the first half of the 20th century. Infection happens after bacterium is ingested. It is generally transmitted to humans via infected milk. Actual human infections are...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related